These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38697615)

  • 1. Population pharmacokinetic modelling and simulation of tranexamic acid in adult trauma patients.
    Stitt G; Spinella PC; Bochicchio GV; Roberts I; Downes KJ; Zuppa AF
    Br J Clin Pharmacol; 2024 Aug; 90(8):1932-1941. PubMed ID: 38697615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial.
    Grassin-Delyle S; Shakur-Still H; Picetti R; Frimley L; Jarman H; Davenport R; McGuinness W; Moss P; Pott J; Tai N; Lamy E; Urien S; Prowse D; Thayne A; Gilliam C; Pynn H; Roberts I
    Br J Anaesth; 2021 Jan; 126(1):201-209. PubMed ID: 33010927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.
    Goobie SM; Meier PM; Sethna NF; Soriano SG; Zurakowski D; Samant S; Pereira LM
    Clin Pharmacokinet; 2013 Apr; 52(4):267-76. PubMed ID: 23371895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimisation of the dosage of tranexamic acid in trauma patients with population pharmacokinetic analysis.
    Grassin-Delyle S; Theusinger OM; Albrecht R; Mueller S; Spahn DR; Urien S; Stein P
    Anaesthesia; 2018 Jun; 73(6):719-729. PubMed ID: 29411358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers.
    Grassin-Delyle S; Semeraro M; Lamy E; Urien S; Runge I; Foissac F; Bouazza N; Treluyer JM; Arribas M; Roberts I; Shakur-Still H
    Br J Anaesth; 2022 Mar; 128(3):465-472. PubMed ID: 34998508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immunologic Effect of Early Intravenous Two and Four Gram Bolus Dosing of Tranexamic Acid Compared to Placebo in Patients With Severe Traumatic Bleeding (TAMPITI): A Randomized, Double-Blind, Placebo-Controlled, Single-Center Trial.
    Spinella PC; Thomas KA; Turnbull IR; Fuchs A; Bochicchio K; Schuerer D; Reese S; Coleoglou Centeno AA; Horn CB; Baty J; Shea SM; Meledeo MA; Pusateri AE; Levy JH; Cap AP; Bochicchio GV;
    Front Immunol; 2020; 11():2085. PubMed ID: 33013880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is tranexamic acid exposure related to blood loss in hip arthroplasty? A pharmacokinetic-pharmacodynamic study.
    Lanoiselée J; Zufferey PJ; Ollier E; Hodin S; Delavenne X;
    Br J Clin Pharmacol; 2018 Feb; 84(2):310-319. PubMed ID: 29193211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment.
    Yang QJ; Jerath A; Bies RR; Wąsowicz M; Pang KS
    Biopharm Drug Dispos; 2015 Jul; 36(5):294-307. PubMed ID: 25704361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tranexamic acid in neonates and infants undergoing cardiac surgery.
    Gertler R; Gruber M; Grassin-Delyle S; Urien S; Martin K; Tassani-Prell P; Braun S; Burg S; Wiesner G
    Br J Clin Pharmacol; 2017 Aug; 83(8):1745-1757. PubMed ID: 28245519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Tranexamic Acid Given as an Intramuscular Injection Compared to Intravenous Infusion in a Swine Model of Ongoing Hemorrhage.
    Spruce MW; Beyer CA; Caples CM; DeSoucy ES; Kashtan HW; Hoareau GL; Grayson JK; Johnson MA
    Shock; 2020 Jun; 53(6):754-760. PubMed ID: 31389905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers.
    Kane Z; Picetti R; Wilby A; Standing JF; Grassin-Delyle S; Roberts I; Shakur-Still H
    Eur J Pharm Sci; 2021 Sep; 164():105893. PubMed ID: 34087356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a randomised controlled trial.
    Hill J; Magill P; Dorman A; Hogg R; Eggleton A; Benson G; McFarland M; Murphy L; Gardner E; Bryce L; Martin U; Adams C; Bell J; Campbell C; Agus A; Phair G; Molloy D; Mockford B; O'Hagan S; Beverland D
    Trials; 2018 Jul; 19(1):413. PubMed ID: 30064517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial.
    Perel P; Prieto-Merino D; Shakur H; Roberts I
    Health Technol Assess; 2013 Jun; 17(24):1-45, v-vi. PubMed ID: 23782457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
    Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of hemorrhage on the pharmacokinetics of tranexamic acid in a swine model.
    Derickson MJ; McClellan JM; Marko ST; Kuckelman JP; Phillips CJ; Barron MR; Martin MJ; Loughren MJ
    J Trauma Acute Care Surg; 2018 Jul; 85(1S Suppl 2):S44-S48. PubMed ID: 29953031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antifibrinolytic and anti-inflammatory effects of multiple doses of oral tranexamic acid in total knee arthroplasty patients: a randomized controlled trial.
    Wang D; Luo ZY; Yu ZP; Liu LX; Chen C; Meng WK; Yu QP; Pei FX; Zhou ZK; Zeng WN
    J Thromb Haemost; 2018 Dec; 16(12):2442-2453. PubMed ID: 30430724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tranexamic acid administration on acute traumatic coagulopathy in rats with polytrauma and hemorrhage.
    Wu X; Benov A; Darlington DN; Keesee JD; Liu B; Cap AP
    PLoS One; 2019; 14(10):e0223406. PubMed ID: 31581265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid in life-threatening military injury and the associated risk of infective complications.
    Lewis CJ; Li P; Stewart L; Weintrob AC; Carson ML; Murray CK; Tribble DR; Ross JD
    Br J Surg; 2016 Mar; 103(4):366-73. PubMed ID: 26791625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury.
    Dixon AL; McCully BH; Rick EA; Dewey E; Farrell DH; Morrison LJ; McMullan J; Robinson BRH; Callum J; Tibbs B; Dries DJ; Jui J; Gandhi RR; Garrett JS; Weisfeldt ML; Wade CE; Aufderheide TP; Frascone RJ; Tallon JM; Kannas D; Williams C; Rowell SE; Schreiber MA
    J Trauma Acute Care Surg; 2020 Nov; 89(5):900-907. PubMed ID: 33105308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid in the prehospital setting: Israel Defense Forces' initial experience.
    Lipsky AM; Abramovich A; Nadler R; Feinstein U; Shaked G; Kreiss Y; Glassberg E
    Injury; 2014 Jan; 45(1):66-70. PubMed ID: 24074828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.